Evogene Ltd. has announced an expanded collaboration with Google Cloud to integrate advanced AI agents into its proprietary ChemPass AI™ platform. This partnership aims to accelerate and scale the discovery and optimization of small molecules for pharmaceutical and agricultural products, leveraging Google Cloud's Vertex AI platform. The integration of AI agents is expected to enhance the speed, precision, and efficiency of Evogene’s discovery workflows, supporting multiple parallel programs and improving cost structure. This marks a significant milestone in the companies' partnership, following their initial collaboration in 2024, and positions Evogene as a leader in next-generation molecular design.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evogene Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: IO84521) on February 10, 2026, and is solely responsible for the information contained therein.